Is SOPHiA GENETICS SA SOPH stock halal to invest in?

Yes, as of August 2026, SOPHiA GENETICS SA stock (SOPH) is classified as a Shariah compliant stock. This verdict follows the screening methodology of AAOIFI (the Accounting and Auditing Organization for Islamic Financial Institutions), whose Shariah Standard No. 21 is the leading global benchmark for screening halal stocks. SOPHiA GENETICS SA currently passes all four AAOIFI financial screens: non-permissible income remains below 5% of total revenue, interest-bearing investments and interest-bearing debt each remain below 30% of market capitalisation, and the company has no impermissible preference share structure. The stock's current purification factor is 98.68%. Compliance is reassessed every month as updated screening data arrives, and a stock's status can change when new financial reports are released. You can always check the current status of SOPHiA GENETICS SA and explore other Shariah compliant stocks in the Tabadulat app.

How often is SOPHiA GENETICS SA SOPH reviewed for Shariah compliance?

Tabadulat reviews SOPHiA GENETICS SA SOPH for Shariah compliance every month. Each review applies the AAOIFI Shariah Standard No. 21 methodology, screening the company's business activities, non-permissible income, interest-bearing investments, interest-bearing debt, and preference shares, against the company's latest available financial data. The process operates under the direct supervision of Tabadulat's dedicated Shariah Supervisory Board of Islamic finance scholars. Because compliance depends on financial ratios that move with market capitalisation and reported results, a stock's status can change from one review to the next. Monthly screening ensures the status shown for SOPHiA GENETICS SA reflects current financial data rather than an outdated assessment, and Tabadulat app users are notified if a holding in their portfolio becomes non-compliant.

Does SOPHiA GENETICS SA SOPH pass the AAOIFI Non Permissible Income criteria?

Yes, as of August 2026, SOPHiA GENETICS SA stock (SOPH) passes the AAOIFI non-permissible income screen. Under AAOIFI Shariah Standard No. 21, income from impermissible sources (such as interest or riba, conventional financial services, alcohol, gambling, or tobacco) must remain below 5% of a company's total revenue. SOPHiA GENETICS SA's income from non-permissible sources is currently within this 5% threshold. Even permissible levels of incidental impure income should still be purified: investors donate the corresponding share of dividends to charity, as reflected in the stock's purification factor. This screen is reassessed monthly using the company's latest financial disclosures.

Does SOPHiA GENETICS SA SOPH pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of August 2026, SOPHiA GENETICS SA stock (SOPH) passes the AAOIFI interest-bearing investments screen. Under AAOIFI Shariah Standard No. 21, the cash a company places in interest-earning instruments (such as conventional deposits, bonds, treasury bills and money-market funds) must remain below 30% of its market capitalisation. This limit ensures shareholders are not materially profiting from riba (interest). SOPHiA GENETICS SA's interest-bearing investments are currently within the 30% threshold. Because the ratio is measured against market capitalisation, it can move with the share price as well as the balance sheet, which is why Tabadulat rescreens the stock every month.

Does SOPHiA GENETICS SA SOPH pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of August 2026, SOPHiA GENETICS SA stock (SOPH) passes the AAOIFI interest-bearing debt screen. Under AAOIFI Shariah Standard No. 21, a company's borrowings that accrue interest (conventional bank loans, bonds and similar riba-based financing) must remain below 30% of its market capitalisation. This cap limits shareholders' exposure to interest-based leverage. SOPHiA GENETICS SA's interest-bearing debt is currently within the 30% threshold. Because market capitalisation changes daily, a company's debt ratio can drift toward or away from the limit even without new borrowing, which is why this screen is reassessed every month.

What is the dividend purification factor for SOPHiA GENETICS SA SOPH stock?

As of August 2026, the dividend purification factor for SOPHiA GENETICS SA (SOPH) is 98.68%. Purification (tazkiyah) is the practice of donating to charity the portion of dividend income attributable to incidental non-permissible sources, typically interest earned on a company's cash, and AAOIFI methodology requires it even for fully compliant stocks. The purification factor is the figure halal investors use to work out that donation on SOPHiA GENETICS SA dividends. It is recalculated with each monthly screening as new financial data arrives, and the Tabadulat app can help you calculate and track purification across your whole portfolio.

Does SOPHiA GENETICS SA SOPH pass the AAOIFI Preference Share screen?

Yes, as of August 2026, SOPHiA GENETICS SA stock (SOPH) passes the AAOIFI preference share screen. AAOIFI Shariah Standard No. 21 prohibits investing in preference shares because they grant holders guaranteed or priority rights to dividends and capital ahead of ordinary shareholders, a structure that conflicts with the Shariah principle that investors should share profit and loss in proportion to their ownership. SOPHiA GENETICS SA has no impermissible preference share structure affecting its ordinary shares, so the stock is compliant on this criterion. Like all AAOIFI screens, this is verified in each monthly review.

Invest Halal, Anytime, Anywhere

Download the Tabadulat app and start building your Shariah-compliant portfolio in minutes.

English

العربية

SOPHiA GENETICS SA

NASDAQ

Shariah-Compliant

Not Shariah

SOPH

About

SOPHiA GENETICS SA

SOPH

Sophia Genetics SA is a global leader in data-driven medicine focused on enabling healthcare institutions to leverage artificial intelligence and data analytics to enhance clinical diagnosis. The company's main purpose is to democratize data-driven medicine, making genomic and other types of patient data insights accessible and actionable for healthcare providers worldwide. Sophia Genetics serves various sectors within the medical field, including oncology, cardiology, and rare genetic disorders, by providing powerful data interpretation solutions that empower personalized treatment plans. Founded in 2011, the company aims to improve patient outcomes by ensuring data standardization and accessibility across global healthcare networks. Its platform integrates a wide array of medical data from genomic sequences to imaging data, allowing for a comprehensive approach to medical data analysis and enhanced collaboration among medical professionals. By making complex medical data easily interpretable, Sophia Genetics plays a significant role in the growing field of precision medicine, driving innovation in healthcare diagnostics and treatment methodologies.

Sector:

Healthcare

Industry:

Health Information Services

Employees:

423

Website:

https://www.sophiagenetics.com

SOPH

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Open your account.

Create your Tabadulat account in minutes: enter your details, complete identity verification, and add funds by secure transfer in multiple currencies. You're ready to start investing in halal stocks the same day.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

SOPHiA GENETICS SA

About

SOPHiA GENETICS SA

SOPH

Frequently asked questions

Is SOPHiA GENETICS SA SOPH stock halal to invest in?

How often is SOPHiA GENETICS SA SOPH reviewed for Shariah compliance?

Does SOPHiA GENETICS SA SOPH pass the AAOIFI Non Permissible Income criteria?

Does SOPHiA GENETICS SA SOPH pass the AAOIFI Interest Bearing Investments criteria?

Does SOPHiA GENETICS SA SOPH pass the AAOIFI Interest Bearing Debt criteria?

What is the dividend purification factor for SOPHiA GENETICS SA SOPH stock?

Does SOPHiA GENETICS SA SOPH pass the AAOIFI Preference Share screen?

How do I buy SOPHiA GENETICS (SOPH) stock?

Open your account.

Deposit.

Screen.